% | $
Quotes you view appear here for quick access.

Kraig Biocraft Laboratories, Inc. Message Board

  • ezndat ezndat Jan 4, 2012 7:18 PM Flag

    Help me out

    How is it that all these articles are basically confirming that they’ve made these strides in developing spider silk and we’re still sitting here trading at 8 cents? I would think that the fact that producing the silk is viable and has been achieved would send us to .5 or $1.00…..Have any of you added on in the past couple sessions, I’m tempted……

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The silk fibers produced by these animals were composite materials that included chimeric silkworm/spider silk proteins integrated in an extremely stable manner. Furthermore, these composite fibers were, on average, tougher than the parental silkworm silk fibers and as tough as native dragline spider silk fibers.

      Reread the abstract and you will have anwsered your own question.

    • VERY few of the news articles even mentioned KBLB at all. KBLB was only mentioned in the PNAS publication in the very fine print as one of the "conflicts of interest". So most investors aren't yet even aware who owns the rights on this technology,

      DESPITE THAT the share price has increased about 10% in only two days! Imagine what may happen when KBLB issues a PR that will get coverage that makes everyone aware of who is the company that owns the technology!

      And then there's the upcoming CC, a real possibility of a deal on Monster SIlk , the results of round 2 of the ZF GMs are due (and are probably what's determining the date of the CC) and more.

      There is a LOT of built in "interest value" that could generate a lot more publicity than most such products get. Spider silk is really going to catch the public's interest. More so because it's being produced in silkworms. Even more so because this is a profoundly new way of producing things.

      Then wait til the platform worm is proven (first product made with it). Not MERELY "self reproducing factories" (the lines of silkworms, but a factory for cranking out self reproducing factories.

      That's not MERELY production moved up to a higher level entirely (self reproducing factories) but production moved up TWO levels at one go: factories (platform worms) that produce A WHOLE RANGE of self reproducing factories for a whole range of products. All at far lower costs. All high tech high value products. Put that together and you get very high profit margins.

      We are only at the very beginning stage of this thing.

      BUT you have to have realistic expectations about how long it will take. Many people owned shares of Microsoft when it was just a couple of nerds in a garage. Very few of them rode it all the way to the top for a 1,000 X gain. Those that were unrealistic in their expectations mostly sold out.

      A research article has confirmed that they have GMed worms to produce silk with some spider silk protein. KBLB may already have worms that produce a lot more of it since the work that that article was written on.

      There will be setbacks and disappointments along the way. Such things are inevitable in biotechnology. There will be delays. The company might fail (this is biotechnology. "stuff" happens.) But if it all comes together the rewards for riding it out will be immense.

    • Good question, though you will not get the answer here. Occasionally there are some posts here worth reading. Mostly though this board serves as a medium for bashers and promoters to incessantly engage in ad hominem attacks against one another to pass the time. I have flipped this stock several times since the first run and recently bought some more when it dipped below .08. We are basically in the same position we were a year ago. I thought at that time that the 1st Gen. silk was going to be brought to market within a few months pending further developments in subsequent generations. Yet here we are still. I would love to see this thing take off, but I am starting to wonder about why we are still in the dark with commercialization attempts (or lack thereof). This thing will likely drop like a rock if Kim doesn't get a deal soon or at least start sharing some substantive information in that regard. New breakthroughs are great, but we need to bring a product to market at some point. Fingers crossed for good news soon.

      • 2 Replies to hinkle_bryan
      • I suspect that the first generation silk was not brought to market because, as it mentions in the peer reviewed paper announcement, the resultant silk is only "on average tougher" than regular silk. I interpret that to mean that statistically the two bell shaped curves of regular and monster silk toughness overlap, and the amount that they overlap each other is such that there would not be enough noticeable difference to warrant the sale of the new silk at a higher price.
        This does detract from the tremendous scientific breakthrough that has been achieved, but only when the modified silk is several orders of magnitude higher in 'ultimate tensile stength' will it become commercially viable.
        (Does anybody have the median values, and standard deviations of the two silks?)
        This will probably take several more generations of 'tweaking' until hopefully the two '6 sigma' bell curves separate and we have a product.

      • IMHO there is very good reason to believe that your questions about the commercialization will be answered at the upcoming CC if not before.

        I'll go into that in considerable depth very soon but I want to get some things nailed down as well as I can beforehand. (I got REALLY raked over the coals at the IHUB board for having the gall to insist that the news accounts DEFINITELY were about KBLB's technology and ND was involved the evening before the publication. People were jumping all over me for being "premature" and jimmybuffet2 was even demanding that I delete the posts. (I suspect he had a strong position of the side of this one.)

        I want to be very sure before I get "too far" ahead.

        (I've experienced "killing the messenger" who bears bad news before, but that was the first time I've been attacked for bringing GOOD news)

        I'm sure it's been a frustrating year if you were counting on commercialization at any time all year. But when investing in biotechnology you need to understand that timing is INHERENTLY uncertain and "stuff" happens. Frequently it's only a delay while some unexpected obstacle is overcome. And it appears that that's what's happened here. No one is "at fault". These kinds of things are INEVITABLE in biological research. What laypersons read is greatly simplified. If it wasn't, they wouldn't understand it at all. The scientists are VERY good and can deal with the complexities and unexpected events, but you have to give them a reasonable amount of time to do it. It very much comes with the territory.

0.04+0.01(+26.10%)3:59 PMEDT